Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of PCI BIOTECH ASA NK 3
No Price
Closing Price XOSL 23.04.2026:
0,07 NOK
23.04.2026 14:48
Current Prices from PCI BIOTECH ASA NK 3
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
London
0JGL.L
NOK
23.04.2026 14:48
0,07 NOK
-
OSLO BORS
PCIB.OL
NOK
23.04.2026 14:25
0,07 NOK
-
Share Float & Liquidity
Free Float72,88 %
Shares Float27,2 M
Shares Outstanding37,33 M
Company Profile for PCI BIOTECH ASA NK 3 Share
PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is in Phase I clinical study; and fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study. It also offers Amphinex, a photosensitiser fimaporfin. The company has collaborative research programs with Bavarian Nordic, BioNTech, Phio Pharmaceuticals, DCprime, eTheRNA immunotherapies, IMV, and Aposense. PCI Biotech Holding ASA is based in Oslo, Norway.
